BioSpace News Archive

This Initial Production Run is Expected to Yield Approximately 8,500 Blister Packs – Concentration of Cannabigerol (“CBG”) has Been Increased to 15mg / Each Piece of Chewing Gum

Ayin Health Solutions (Ayin), the national population health management company of Providence St. Joseph Health, announced today that its chief executive officer, Rhonda Medows , MD, FAAFP has been named as chairperson-elect of the Board of Trustees for the Catholic Health Association of the United States (CHA) for fiscal year 2021

Verrica Pharmaceuticals Inc. today announced the presentation of new pooled data from two analyses of the Phase 3 CAMP trials of VP-102 (cantharidin 0.7% topical solution), Verrica’s lead product candidate for the treatment of molluscum contagiosum (molluscum). These data are available in poster format online by the American Academy of Dermatology for the 2020 annual meeting, which was previously scheduled for March 20-24 in Denver, Colorado.

The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 36 cents per share. This marks the 386 th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Aug. 17, 2020, to shareholders of record at the close of business on July 15, 2020 . Abbott has inc

Oceans Healthcare and the Massachusetts General Hospital Department of Psychiatry have signed an agreement that will give patients of the behavioral health network access to some of the world’s most highly qualified psychiatrists.

Today MBET Health announces a proactive solution, the Miracle Dressing Wound Care System (MDS), for the impending surge of pressure injuries expected because of confinements caused by COVID-19 mitigation.

Q BioMed (OTC: QBIO) is proud to be a Supporter of the Living Beyond Breast Cancer (LBBC) 2020 Virtual Conference on Metastatic Breast Cancer taking place June 13 and 14, 2020.

Cancers cells use a special technique to propagate; they delete their “programmed death” gene through mutation, “forget” to die when their lifetime is over, and continue to grow instead

LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit organization, announced today that Robert Winn, MD, Director, Virginia Commonwealth University Massey Cancer Center, joined LUNGevity’s Board of Directors.

DCprime, the front-runner in the field of relapse vaccines, in collaboration with the University of Bergen, today announced the presentation of a novel preclinical animal model tailored for cancer vaccine research at the virtual 25th European Hematology Association Congress (EHA).